RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jorge Duconge to Radioligand Assay

Back to Details
This is a "connection" page, showing publications Jorge Duconge has written about Radioligand Assay.
Jorge Duconge
Connection Strength
0.024
Radioligand Assay
  1. Prats PA, Duconge J, Valenzuela C, Berlanga J, Edrosa CR, Fern?ndez-S?nchez E. Disposition and receptor-site binding of (125)I-EGF after topical administration to skin wounds. Biopharm Drug Dispos. 2002 Mar; 23(2):67-76.
    View in: PubMed
    Score: 0.013
  2. Morales AA, Ducong? J, Alvarez-Ruiz D, Becquer-Viart ML, N??ez-Gandolff G, Fern?ndez E, Caballero-Torres I, Iznaga-Escobar N. Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies. Nucl Med Biol. 2000 Feb; 27(2):199-206.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support